Lol. I read Dr T's post and before I even read your post decided that I better lift probability for Pillar 1 to 15% from 10%. This puts it at mid-Phase 1 based on the criteria explained in the linkedin post. Safety is already known.
https://www.linkedin.com/pulse/5-step-approach-early-stage-biotech-drugs-valuation-riccardo-lowi/
I will lift it to 20% once RAC have their own preclinical data for FTO.
On this basis my calculation of fair value for buyout using risked NPV has been moved up to $83 (from $75).
Pillar 1 - FTO (new thread), page-438
-
- There are more pages in this discussion • 2,554 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.56 |
Change
-0.015(0.95%) |
Mkt cap ! $265.8M | |||
| Open | High | Low | Value | Volume |
| $1.61 | $1.63 | $1.56 | $160.1K | 100.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 222 | $1.56 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.60 | 500 | 1 |
View Market Depth
| Last trade - 16.10pm 14/08/2024 (20 minute delay) ? |
| RAC (ASX) Chart |